Genomic information plays a critical role in precision medicine by identifying genetic variations that influence disease risk, progression, and response to treatment. For instance, the identification of BRCA1 and BRCA2 mutations can help determine a woman's risk for developing breast or ovarian cancer. This information can guide decisions regarding preventive measures such as prophylactic surgery or more aggressive screening protocols.
